Table 2: Summary of Timelines to Clinical Use*.
| Organization/Year | Second-Generation Nanodevice | Estimate of When Nanodevice Will Be in Clinical Use |
|---|---|---|
| NCI 2001 (39) | Imaging/detection (e.g., QDs) | ~2006–2016 |
| Therapeutic (e.g., nanoshell) | ~2006–2016 | |
| Combined (e.g., dendrimer) | ~2016–2020 | |
| NCI 2004 (40) | Imaging/detection | ~2009–2019 |
| Therapeutic | ~2009–2019 | |
| Combined | ~2019–2024 | |
| RAND 2006 (38) | Combined | unlikely before 2021 |
| Centre for Technology Assessment TA Swiss 2003 (37) | Imaging | ~ 2005–2010 |
| Therapeutic | ~ 2008–2013 | |
| Combined | ~ 2010–2013 |
*
NCI indicates National Cancer Institute; QD, quantum dot.